Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
National Institute on Drug Abuse (NIDA) |
---|---|
Information provided by: | National Institute on Drug Abuse (NIDA) |
ClinicalTrials.gov Identifier: | NCT00265278 |
The purpose of this study is to assess the potential interactions between intravenous methamphetamine and oral Modafinil.
Condition | Intervention | Phase |
---|---|---|
Amphetamine-Related Disorders |
Drug: Modafinil |
Phase I |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Safety Study |
Official Title: | Double-Blind, Placebo-Controlled Assessment of Interactions Between Intravenous Methamphetamine and Modafinil |
Estimated Enrollment: | 16 |
Study Start Date: | March 2005 |
Estimated Study Completion Date: | March 2006 |
The primary aims of this experiment are to determine if there are significant safety interactions between oral modafinil and intravenous methamphetamine. Safety will be assessed by measuring adverse events and cardiovascular responses of heart rate (HR), blood pressure (BP), and electrocardiogram (ECG) and stroke distance (ICG).
Ages Eligible for Study: | 18 Years to 45 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
United States, California | |
U of CA, San Francisco | |
San Francisco, California, United States, 94143 |
Principal Investigator: | Reese Jones, M.D. | Langley Porter Psychiatric Institute |
Study ID Numbers: | NIDA-CPU-0008-1 |
Study First Received: | December 13, 2005 |
Last Updated: | October 25, 2007 |
ClinicalTrials.gov Identifier: | NCT00265278 |
Health Authority: | United States: Food and Drug Administration |
Methamphetamine Dopamine Mental Disorders Amphetamine-Related Disorders |
Substance-Related Disorders Disorders of Environmental Origin Amphetamine Modafinil |
Dopamine Uptake Inhibitors Neurotransmitter Uptake Inhibitors Neurotransmitter Agents Molecular Mechanisms of Pharmacological Action Adrenergic Agents Sympathomimetics Adrenergic Uptake Inhibitors Physiological Effects of Drugs Central Nervous System Stimulants |
Protective Agents Neuroprotective Agents Pharmacologic Actions Autonomic Agents Therapeutic Uses Dopamine Agents Peripheral Nervous System Agents Central Nervous System Agents |